U.S. judge tosses verdict against AbbVie in AndroGel case

(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news